|
|||||
|
|
Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study |
|
| Authors: | Iris de Nie Chantal M Wiepjes Christel JM de Blok R Jeroen A van Moorselaar Garry LS Pigot Tim M van der Sluis Ellis Barbé Patrick van der Voorn Norah M van Mello Judith Huirne Martin den Heijer |
| Institution: | 1. Department of Endocrinology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands;2. Department of Endocrinology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands
Center of Expertise on Gender Dysphoria, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands;3. Department of Urology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands;4. Center of Expertise on Gender Dysphoria, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands Department of Urology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands;5. Department of Pathology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands;6. Center of Expertise on Gender Dysphoria, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands Department of Obstetrics and Gynecology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands;7. Department of Obstetrics and Gynecology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands |
| Abstract: | |
| Keywords: | testicular cancer transgender gender-affirming hormonal treatment gender dysphoria carcinogenesis oestrogen #TesticularCancer #tscsm #uroonc |